Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Patients With High-Bleeding Risk.

Hyojung Ryu; S. A. Kim; Dong Oh Kang; Byung Joo Choi; Ae-Young Her

doi:10.1002/ccd.70528

February 24, 2026

Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Patients With High-Bleeding Risk.

View at Publisher

Ask AI

Bookmark

Share

Key Points

The research aims to assess the effectiveness of drug-coated balloon (DCB) treatment versus drug-eluting stent (DES) only in patients with high-bleeding risk (HBR).
Compared outcomes of DCB-based percutaneous coronary intervention (PCI) and DES-only treatments.
Analyzed major adverse cardiovascular events (MACE) among patients with HBR.
DCB-based PCI was associated with a significantly lower risk of MACE compared to DES-only treatment.
Improving outcomes for patients with high-bleeding risk was suggested as a key advantage of DCB.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Observational study shows lower risk of adverse cardiovascular events in high-bleeding risk patients using drug-coated balloons, suggesting a safer treatment option.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ryu et al. (2026) studied this question.

synapsesocial.com/papers/699fe2fe95ddcd3a253e682d https://doi.org/10.1002/ccd.70528

View at Publisher

Ask AI

Bookmark

Share

Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Patients With High-Bleeding Risk.

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Patients With High-Bleeding Risk.

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading